MarketCap
AbCellera Biologics ABCL
$ 10.89
4.11%
Facebook
X
Telegram
AbCellera Biologics Total Current Liabilities | ABCL
Annual Total Current Liabilities AbCellera Biologics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64.3 M | 76.6 M | 119 M | 118 M | 121 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 121 M | 64.3 M | 99.8 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Фармсинтез
LIFE
|
1.02 B | - | - | - |  Russia |
 |
AbbVie
ABBV
|
43.3 B | $ 257.12 | 0.86 % | $ 455 B |  USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M |  Israel |
 |
Evelo Biosciences
EVLO
|
12.4 M | - | -14.46 % | $ 27.9 M | USA |
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
64.5 M | - | -15.15 % | $ 60.3 M |  Britain |
 |
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | USA |
 |
Abeona Therapeutics
ABEO
|
29.6 M | $ 5.42 | 0.18 % | $ 287 M | USA |
 |
iTeos Therapeutics
ITOS
|
40.4 M | - | - | $ 411 M | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
2.84 M | $ 4.63 | 21.05 % | $ 20 M | Israel |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | USA |
 |
BioXcel Therapeutics
BTAI
|
53.9 M | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
Allakos
ALLK
|
17.8 M | - | - | $ 28.6 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
1.71 M | $ 23.52 | 458.67 % | $ 98.9 M | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
20.9 M | $ 2.0 | 0.3 % | $ 726 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | USA |
 |
Alpine Immune Sciences
ALPN
|
42 M | - | - | $ 2.17 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
6.01 M | $ 5.12 | 0.1 % | $ 981 M |  Canada |
 |
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | USA |
 |
NextCure
NXTC
|
10.6 M | $ 7.0 | 0.55 % | $ 19.9 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
36.9 M | - | 17.91 % | $ 11.1 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
277 M | $ 27.83 | 0.32 % | $ 4.69 B | USA |
 |
Axcella Health
AXLA
|
14.1 M | - | -16.42 % | $ 249 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
21.8 M | - | 57.95 % | $ 12.8 M | USA |
 |
Atreca
BCEL
|
16.3 M | - | -11.76 % | $ 5.79 M | USA |
 |
Berkeley Lights
BLI
|
45.5 M | - | -7.31 % | $ 87 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
5.4 M | - | -74.18 % | $ 955 K | USA |
 |
Achieve Life Sciences
ACHV
|
9.08 M | $ 7.06 | 0.41 % | $ 308 M | USA |
 |
Baudax Bio
BXRX
|
21.5 M | - | 0.59 % | $ 63 K | USA |
 |
Calithera Biosciences
CALA
|
7.39 M | - | -10.95 % | $ 876 K | USA |
 |
CymaBay Therapeutics
CBAY
|
36.8 M | - | - | $ 3.45 B | USA |
 |
Codiak BioSciences
CDAK
|
27.2 M | - | -55.98 % | $ 2.15 M | USA |
 |
ChemoCentryx
CCXI
|
63 M | - | - | $ 3.74 B | USA |
 |
Avid Bioservices
CDMO
|
70.6 M | - | - | $ 789 M | USA |
 |
Cerevel Therapeutics Holdings
CERE
|
92.2 M | - | - | $ 7.29 B | USA |
 |
Aclaris Therapeutics
ACRS
|
28.6 M | $ 5.32 | 1.27 % | $ 652 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
20.1 M | - | - | $ 169 M | USA |
 |
Adagene
ADAG
|
25.2 M | $ 3.4 | 2.72 % | $ 201 M |  China |
 |
ADC Therapeutics SA
ADCT
|
70.2 M | $ 1.07 | 0.45 % | $ 136 M |  Schweiz |
 |
Adial Pharmaceuticals
ADIL
|
1.4 M | $ 4.9 | 0.08 % | $ 3.28 M | USA |
 |
ADMA Biologics
ADMA
|
69.5 M | $ 9.23 | 0.16 % | $ 2.2 B | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
89.9 M | $ 24.2 | 0.08 % | $ 3.67 B | USA |
 |
Agenus
AGEN
|
323 M | $ 6.94 | 0.73 % | $ 206 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
82.2 M | $ 33.6 | 0.16 % | $ 1.95 B | USA |